Skip to content

BBOTBRIDGEBIO ONCOLOGY THERAPEUT

CUSIP 107924102 · common stock

1 tracked investor held BRIDGEBIO ONCOLOGY THERAPEUT (BBOT) at the end of Q3 2026, worth $70.5K. The largest holder was Adar1 Capital Management, with 0.0% of its portfolio. Adar1 Capital Management opened a new position this quarter.

Holders · Q3 2026
1
New holders
1
Value held
$70.5K
Quarter-end price (est.)
$4.10

Investors holding BBOT · Q3 2026

InvestorWeightSharesValueChange
Adar1 Capital Management
ADAR1 Capital Management, LLC
0.00%17,183$70.5KNEW

Sold out this quarter

InvestorPrior weightPrior sharesPrior valueChange
Chuck Royce0.02%384,941$2.9MEXIT

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026111$70.5K$4.10
Q2 2026100$2.9M$7.62
Q1 2026111$5.7M$8.95
Q4 2025100$2.8M$12.52